Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial
Authors
Keywords
-
Journal
LANCET
Volume 400, Issue 10361, Pages 1405-1416
Publisher
Elsevier BV
Online
2022-09-18
DOI
10.1016/s0140-6736(22)01787-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial
- (2022) Felix Mahfoud et al. LANCET
- Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis
- (2022) Milad Nazarzadeh et al. Lancet Diabetes & Endocrinology
- Systolic Blood Pressure Time in Target Range and Cardiovascular Outcomes in Patients With Hypertension
- (2021) Nayyra Fatani et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis
- (2021) Kazem Rahimi et al. LANCET
- Renal Denervation for Hypertension
- (2021) Yousif Ahmad et al. JACC-Cardiovascular Interventions
- The REDUCE HTN: REINFORCE
- (2020) Michael A. Weber et al. JACC-Cardiovascular Interventions
- Assessment of Long-term Benefit of Intensive Blood Pressure Control on Residual Life Span
- (2020) Muthiah Vaduganathan et al. JAMA Cardiology
- Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial
- (2020) Michael Böhm et al. LANCET
- 12-Month Results From the Unblinded Phase of the RADIANCE-HTN SOLO Trial of Ultrasound Renal Denervation
- (2020) Michel Azizi et al. JACC-Cardiovascular Interventions
- Sham-Controlled Randomized Trials of Catheter-Based Renal Denervation in Patients With Hypertension
- (2019) Partha Sardar et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effect of Systolic and Diastolic Blood Pressure on Cardiovascular Outcomes
- (2019) Alexander C. Flint et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial
- (2018) David E Kandzari et al. LANCET
- Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial
- (2018) Michel Azizi et al. LANCET
- Time spent at blood pressure target and the risk of death and cardiovascular diseases
- (2018) Sheng-Chia Chung et al. PLoS One
- Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association
- (2018) Robert M. Carey et al. HYPERTENSION
- Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
- (2017) Emmanuela Gakidou et al. LANCET
- Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial
- (2017) Raymond R Townsend et al. LANCET
- Impact of Renal Denervation on Patients With Obstructive Sleep Apnea and Resistant Hypertension – Insights From the SYMPLICITY HTN-3 Trial –
- (2016) Kazuomi Kario et al. CIRCULATION JOURNAL
- Effect of Catheter-Based Renal Denervation on Morning and Nocturnal Blood Pressure
- (2015) Kazuomi Kario et al. HYPERTENSION
- Impact of Lesion Placement on Efficacy and Safety of Catheter-Based Radiofrequency Renal Denervation
- (2015) Felix Mahfoud et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- An analysis of the blood pressure and safety outcomes to renal denervation in African Americans and Non-African Americans in the SYMPLICITY HTN-3 trial
- (2015) John M. Flack et al. Journal of the American Society of Hypertension
- Non-adherence to cardiovascular medications
- (2014) K. Kolandaivelu et al. EUROPEAN HEART JOURNAL
- Predictors of blood pressure response in the SYMPLICITY HTN-3 trial
- (2014) D. E. Kandzari et al. EUROPEAN HEART JOURNAL
- Impact of Renal Denervation on 24-Hour Ambulatory Blood Pressure
- (2014) George L. Bakris et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A Controlled Trial of Renal Denervation for Resistant Hypertension
- (2014) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Catheter-Based Renal Denervation for Resistant Hypertension: Rationale and Design of the SYMPLICITY HTN-3 Trial
- (2012) David E. Kandzari et al. CLINICAL CARDIOLOGY
- Resistant hypertension: a frequent and ominous finding among hypertensive patients with atherothrombosis
- (2012) Dharam J. Kumbhani et al. EUROPEAN HEART JOURNAL
- Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study
- (2009) Henry Krum et al. LANCET
- Analytical approaches to reporting long-term clinical trial data
- (2008) Kim A. Papp et al. CURRENT MEDICAL RESEARCH AND OPINION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search